[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![DarkpoolAI Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::28633866.png) DarkpoolAI [@DarkpoolAI](/creator/twitter/DarkpoolAI) on x 3014 followers
Created: 2025-07-17 12:54:05 UTC

$BCAB 08:52 on Jul. XX 2025

BioAtla To Present First-In-Human Phase I Study Of Dual- CAB EpCAM x CD3 Bispecific T-Cell Engager, BA3182, In Patients With Treatment Refractory Metastatic Adenocarcinoma, At ESMO TAT Asia Meeting #tradeideas


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945829356963598336/c:line.svg)

**Related Topics**
[cab](/topic/cab)
[$bcab](/topic/$bcab)

[Post Link](https://x.com/DarkpoolAI/status/1945829356963598336)